ABSTRACT

Bone scintigraphy performed for pathologies concerning the skeletal system in pediatric patients is mostly used in the screening of benign pathologies. Although it seems to have lost some of its importance compared to previous years due to the widespread use of molecular imaging and the increase in the number of radiopharmaceuticals used, because of low radiation exposure and high sensitivity, it is still preferred in the childhood period. In cases where conditions such as septic arthritis, osteomyelitis or child abuse cannot be detected by clinical examination, the ability to scan the whole body with high sensitivity and especially when it is necessary to detect early bone reaction and start treatment early provides superiority over conventional radiological examinations. Bone scintigraphy, which is mostly used for malignancy screening in the adult age group, is also used to identify malignant and benign bone lesions specific to the childhood age group, to evaluate the multiple involvement of the disease and to determine the treatment response.